Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year

被引：0
|
作者：
Golden, David B. K. [1 ]
Fahrenholz, John M. [2 ]
Renahan, Kevin E. [3 ]
Khairallah, Sandrine [4 ]
Abiteboul, Kathy [4 ]
机构：
[1] Medstar Franklin Sq Med Ctr, Baltimore, MD USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Stallergenes Greer, Cambridge, MA USA
[4] Stallergenes Greer, Antony, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.148
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
191
引用
收藏
页码：AB60 / AB60
页数：1
相关论文
共 50 条
  • [41] Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR
    Didier, A.
    Worm, M.
    Horak, F.
    Melac, M.
    De Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Galvain, S.
    Malling, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB151 - AB151
  • [42] Safety Of 300IR 5-Grass Tablet In Grass Pollen-Allergic Children With Or Without Controlled Asthma: Further Data From A Post-Marketing Observational Study
    Golden, David B. K.
    Gerstlauer, Michael
    Szepfalusi, Zsolt
    De Blic, Jacques
    Geng, Bob
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB198 - AB198
  • [43] Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis
    Zeldin, Robert K.
    Amistani, Yann
    Cognet-Sice, Josiane
    Abiteboul, Kathy
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [44] Sustained and post-treatment efficacy of a 5-grass pollen allergen extract sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Zeldin, R. K.
    Melac, M.
    Amistani, Y.
    Didier, A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 298 - 298
  • [45] Assessment of timothy grass-specific serum IgE and IgG4 in a long-term study of 300IR five-grass pollen sublingual tablet
    Malling, H.
    Cadic, V
    Cognet-Sice, J.
    Zeldin, R.
    ALLERGY, 2012, 67 : 418 - 418
  • [46] Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
    Didier, Alain
    Malling, Hans-Jorgen
    Worm, Margitta
    Horak, Friedrich
    Sussman, Gordon L.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2015, 5
  • [47] Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis
    Gerstlauer, Michael
    Szepfalusi, Zsolt
    Golden, David
    Geng, Bob
    de Blic, Jacques
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (01) : 70 - 80
  • [48] Modalities of use and tolerance of a 300IR 5-grass pollen tablet treatment in real life in patients consulting allergology specialists in France
    Devillier, P.
    Serrano, E.
    Lheritier-Barrand, M.
    Chanal, I
    Migueres, M.
    ALLERGY, 2017, 72 : 160 - 161
  • [49] Impact of discontinuous administration of a 300IR sublingual tablet of five-grass-pollen extract on symptomatic treatment use
    Didier, A.
    Malling, H.
    Worm, M.
    Soulie, S.
    Abiteboul, K.
    Zeldin, R.
    ALLERGY, 2012, 67 : 415 - 415
  • [50] Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America
    Moingeon, Philippe
    Cox, Linda
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (06) : 617 - 623
12345